The present invention discloses a novel polypeptide-human galectin 15 and a polynucleotide
encoding the same, as well as a method of producing the polypeptide by DNA recombinant
technology. The present invention also discloses methods of using the polypeptide
in treatment of various diseases, such as malignant tumor, blood disease, HIV infection,
immunological disease and various inflammations. The present invention also discloses
an antagonist against the polypeptide and the therapeutic use of the same.
